Market Access/ News/ News/ News/ R&D Cidara and Mundipharma prep filings for antifungal rezafungin Phil Taylor antifungal, Cidara Therapeutics, infectious diseases, Mundipharma, rezafungin 0 Comment Mundipharma and Cidara Therapeutics have reported the results of a phase 3 trial of their new once-weekly antifungal Share X Cidara and Mundipharma prep filings for antifungal rezafungin https://pharmaphorum.com/news/cidara-and-mundipharma-prep-filings-for-antifungal-rezafungin/